You have 8 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

HY-0102, solid tumors

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Solid Tumor Trial in Shanghai (HY-0102)

Not yet recruiting
  • Advanced Solid Tumor
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Oct 19, 2023

Locally Advanced/Metastatic Solid Tumors Trial (HY-0102)

Not yet recruiting
  • Locally Advanced/Metastatic Solid Tumors
  • (no location specified)
Jan 4, 2022

Advanced Solid Tumors Trial in Worldwide (MK-1088, Pembrolizumab)

Recruiting
  • Advanced Solid Tumors
  • Miami, Florida
  • +10 more
Jan 12, 2023

Solid Tumor, Epithelial Ovarian Cancer, Fallopian Tube Cancer Trial in United States (ZN-c3)

Recruiting
  • Solid Tumor
  • +9 more
  • Tucson, Arizona
  • +3 more
Aug 12, 2021

Tumors Trial in Worldwide (MK-4830, Pembrolizumab, Carboplatin)

Recruiting
  • Neoplasms
  • San Francisco, California
  • +31 more
Dec 23, 2022

PIK3CA Mutation-Related Tumors Trial in Shanghai (WX390)

Completed
  • PIK3CA Mutation-Related Tumors
  • Shanghai, Shanghai, China
    Shanghai East Hospital
Nov 9, 2023

Relapsed or Refractory Solid Tumors Trial in Worldwide (Lenvatinib)

Active, not recruiting
  • Relapsed or Refractory Solid Tumors
  • Aurora, Colorado
  • +48 more
Oct 10, 2022

PTEN-null Advanced Solid Tumors Trial in New York (Leflunomide)

Not yet recruiting
  • PTEN-null Advanced Solid Tumors
  • New York, New York
    Icahn School of Medicine at Mount Sinai
Jul 8, 2022

Locally Advanced (Unresectable) or Metastatic Solid Tumor Malignancies Trial in Chuo-ku (ASP1948)

Completed
  • Locally Advanced (Unresectable) or Metastatic Solid Tumor Malignancies
  • Chuo-ku, Tokyo, Japan
    Site JP810001
Jan 17, 2023

Solid Tumor, Adult Trial in Beijing (Vaccine)

Not yet recruiting
  • Solid Tumor, Adult
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Aug 3, 2023

Ovarian Cancer, NSCLC, ESCC Trial in United States (ASP0739, Pembrolizumab)

Active, not recruiting
  • Ovarian Cancer
  • +3 more
  • Duarte, California
  • +6 more
Jan 21, 2023

Tooth, Impacted Trial (Hyaluronic acid gel, Hyaluronic acid gel + carrier)

Recruiting
  • Tooth, Impacted
  • Hyaluronic acid gel
  • Hyaluronic acid gel + carrier
  • Vienna, Austria
    University Clinic of Dentistry, Medical University of Vienna
Aug 29, 2022

Advanced or Metastatic Solid Tumors Trial (Naporafinib, Trametinib)

Not yet recruiting
  • Advanced or Metastatic Solid Tumors
  • (no location specified)
Jun 21, 2023

Her2-positive/Low-expression Urinary and Digestive Tract Tumors Trial in Beijing (BL-M07D1)

Not yet recruiting
  • Her2-positive/Low-expression Urinary and Digestive Tract Tumors
  • Beijing, Beijing, China
    Cancer Hospital, Chinese Academy of Medical Sciences
Sep 8, 2023

Alveolar Osteitis Trial (Hyaluronic acid gel, Hyaluronic acid gel + carrier)

Recruiting
  • Alveolar Osteitis
  • Hyaluronic acid gel
  • Hyaluronic acid gel + carrier
  • Vienna, Austria
    University Clinic of Dentistry, Medical University of Vienna
Aug 29, 2022

HER2-expressing Advanced Solid Tumors Trial (SHR-A1811 combined with Pyrotinib., SHR-A1811 combined with other antitumor

Not yet recruiting
  • HER2-expressing Advanced Solid Tumors
  • SHR-A1811 combined with Pyrotinib.
  • SHR-A1811 combined with other antitumor therapies
  • (no location specified)
Aug 28, 2023

Advanced Solid Tumor Trial in China (7MW3711 for injection)

Not yet recruiting
  • Advanced Solid Tumor
  • 7MW3711 for injection
  • Changsha, Hunan, China
  • +3 more
Aug 18, 2023

Advanced Solid Tumor Trial (7MW3711 for injection)

Not yet recruiting
  • Advanced Solid Tumor
  • 7MW3711 for injection
  • (no location specified)
Aug 18, 2023

COVID-19, COVID-19 Acute Respiratory Distress Syndrome Trial (TTI-0102, Placebo)

Not yet recruiting
  • COVID-19
  • COVID-19 Acute Respiratory Distress Syndrome
  • (no location specified)
May 13, 2022

Advanced or Metastatic Solid Tumors, Advanced or Metastatic Colorectal Cancer (mCRC) Trial in Gilbert, Aurora, Houston (CA102N,

Enrolling by invitation
  • Advanced or Metastatic Solid Tumors
  • Advanced or Metastatic Colorectal Cancer (mCRC)
  • Gilbert, Arizona
  • +2 more
Mar 2, 2022

Recurrent Pregnancy Loss Trial in Aalborg

Recruiting
  • Recurrent Pregnancy Loss
    • Aalborg, Denmark
      The Centre for Recurrent Pregnancy Loss of Western Denmark, Depa
    Apr 30, 2022

    Lymphocytes, Tumor-Infiltrating Trial in Saint Petersburg (Tumor Infiltrating Lymphocytes, Fludarabine, Cyclophosphamide,

    Not yet recruiting
    • Lymphocytes
    • Tumor-Infiltrating
    • Tumor Infiltrating Lymphocytes, Fludarabine, Cyclophosphamide, Interleukin-2
    • Saint Petersburg, Florida
    • +1 more
    Sep 15, 2023

    Advanced Solid Tumor Trial in Chengdu (Dual-targeting CLDN18.2 and PD-L1 CAR-T cells)

    Not yet recruiting
    • Advanced Solid Tumor
    • Dual-targeting CLDN18.2 and PD-L1 CAR-T cells
    • Chengdu, Sichuan, China
      West China Hospital, Sichuan University
    Oct 9, 2023

    Trial (Cemiplimab)

    Available
      • (no location specified)
      Nov 9, 2023

      Colon Cancer Trial in Qingdao (Chimeric antigen receptor T cell preparation targeting GCC)

      Recruiting
      • Colon Cancer
      • Chimeric antigen receptor T cell preparation targeting GCC
      • Qingdao, Shandong, China
        The Affiliated Hospital of Qingdao University
      May 16, 2023